Trioxin - 68025-041-02 - (Chloroxylenol, Benzocaine and Hydrocortisone Acetate)

Alphabetical Index


Drug Information of Trioxin

Product NDC: 68025-041
Proprietary Name: Trioxin
Non Proprietary Name: Chloroxylenol, Benzocaine and Hydrocortisone Acetate
Active Ingredient(s): 15; 1; 10    mg/mL; mg/mL; mg/mL & nbsp;   Chloroxylenol, Benzocaine and Hydrocortisone Acetate
Administration Route(s): AURICULAR (OTIC)
Dosage Form(s): SOLUTION/ DROPS
Coding System: National Drug Codes(NDC)

Labeler Information of Trioxin

Product NDC: 68025-041
Labeler Name: Vertical Pharmaceuticals, Inc
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number:
Marketing Category: UNAPPROVED OTHER
Start Marketing Date: 20090702

Package Information of Trioxin

Package NDC: 68025-041-02
Package Description: 12 BOTTLE in 1 BOX (68025-041-02) > 2 mL in 1 BOTTLE

NDC Information of Trioxin

NDC Code 68025-041-02
Proprietary Name Trioxin
Package Description 12 BOTTLE in 1 BOX (68025-041-02) > 2 mL in 1 BOTTLE
Product NDC 68025-041
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Chloroxylenol, Benzocaine and Hydrocortisone Acetate
Dosage Form Name SOLUTION/ DROPS
Route Name AURICULAR (OTIC)
Start Marketing Date 20090702
Marketing Category Name UNAPPROVED OTHER
Labeler Name Vertical Pharmaceuticals, Inc
Substance Name BENZOCAINE; CHLOROXYLENOL; HYDROCORTISONE ACETATE
Strength Number 15; 1; 10
Strength Unit mg/mL; mg/mL; mg/mL
Pharmaceutical Classes Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]

Complete Information of Trioxin


General Information